“The Complement C3a And C3a Receptor Pathway Indiabetic Patients With Entamobra Histolytica, Cryptospridium Parvum”, Int. J. Environ. Sci., vol. 11, no. 1s, pp. 878–882, Mar. 2025, doi: 10.64252/srkrg656.